RecruitingNot ApplicableNCT07218133

Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery


Sponsor

Alexander T. Yahanda

Enrollment

50 participants

Start Date

Oct 8, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study is a randomized controlled trial that will evaluate the effect of non-invasive auricular vagal nerve stimulation on inflammatory markers, glycemic control, postoperative pain, and inflammation-related clinical outcomes after long-segment spinal fusion surgeries when compared to current accepted management.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Auricular vagus nerve stimulation and a medical device called Sham Auricular Vagus nerve Stimulation for people with cytokine levels, hyperglycemia, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAuricular vagus nerve stimulation

Transcutaneous auricular vagal nerve stimulation

DEVICESham Auricular Vagus nerve Stimulation

Transcutaneous auricular vagal nerve stimulator applied without utilizing stimulating current.


Locations(1)

Washington University School of Medicine

St Louis, Missouri, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07218133


Related Trials